Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
Catherine B JohannesDaniel C BeachlerJ Bradley LaytonHeather E DanyshRyan ZiemieckiAlejandro AranaJade DinhLing LiBrian CalingaertManel PladevallPhillip R HuntHungta ChenCecilia KarlssonKristina JohnssonAlicia W GilsenanPublished in: Drug safety (2022)
European Union Post-Authorisation Studies Register, EUPAS 11684; ClinicalTrials.gov, NCT02695082.
Keyphrases